BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 4th Quarter - Report

SUN PHARMACEUTICAL INDUSTRIES, INC.

via FIERCE GOVERNMENT RELATIONS

4th Quarter (Oct 1 - Dec 31) · 2023Posted Jan 22, 2024Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: SUN PHARMACEUTICAL INDUSTRIES, INC.
Description: Generic Pharmaceutical Company
Location: New York · United States of America

Registrant

Firm: FIERCE GOVERNMENT RELATIONS
Description: Government Relations and Consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Drug Shortages
LobbyistsKATE HULL · KIRSTEN CHADWICK · ALEIX JARVIS · TYLER STEPHENS · WILLIAM PIPER · WILLIAM KIRK BLALOCK · MICHAEL CHAPPELL · ERIC ZULKOSKY
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

SUN PHARMACEUTICAL INDUSTRIES, INC. — Receipts Report